Negocie Gilead GILD

Gráfico Gilead ao vivo

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Gilead news

Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Últimas notícias

Mostrar mais
Liam James 2025 Sep 24, 09:20

Macron Urges Trump to End Gaza Conflict for Nobel Peace Prize Consideration

Ava Grace 2025 Sep 24, 08:20

BOJ Rate Hike in October? Examining the Possibilities and Challenges

Liam James 2025 Sep 24, 08:20

Xiaomi's Transformation: Lei Jun's Anticipated Speech and New Product Launches

Ava Grace 2025 Sep 24, 08:20

NATO on Alert as Suspected Russian Drone Incursions Escalate Tensions

Liam James 2025 Sep 24, 06:20

Citigroup Exits Yield Curve Steepening Trade Amid Fed Independence Reassurance

Sophia Claire 2025 Sep 24, 04:20

Nvidia & OpenAI's $100B Bet: Innovation Catalyst or AI Bubble Inflator?

Emma Rose 2025 Sep 24, 03:20

Tether Eyes $20 Billion Funding Round: Potential $500 Billion Valuation

Emma Rose 2025 Sep 24, 02:20

Trump Cancels Budget Meeting, Heightening Government Shutdown Risk

Info

Spread

0.70

Spread (%)

0.6141 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Quarta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quinta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

141948305408

Ações em circulação

1240806916

Data dos rendimentos (Próxima)

2013-01-28

Rendim Divid

2025-09-29

Data Ex-Dividendos

2025-09-15

Taxa anual futura de dividendos

3.16

Rendimento anual futuro de dividendos

0.0281

EPS

5.13

Saiba mais sobre este instrumento

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot